FDA Webview

Free FDA Notices

Comments Extended on Compounded Drug MOU


Federal Register Notice: FDA is extending the comment period until 7/20 for a draft standard memorandum of understanding (MOU) entitled “Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products Between the State of [insert State] and the U.S. Food and Drug Administration,” from the 2/19 Federal Register. The draft standard MOU describes the responsibilities of any state that chooses to sign the MOU in investigating and responding to complaints related to compounded human drug products distributed outside the state and in addressing the interstate distribution of inordinate amounts of compounded human drug products. To view this notice, click here.